SEC 13F Intelligence

D. E. Shaw & Co., Inc. / ABBV

D. E. Shaw & Co., Inc.’s Abbvie Inc Position

Does D. E. Shaw & Co., Inc. own Abbvie Inc (ABBV)? Yes — 673.0K shares worth $146M (+0.09% of its 13F portfolio) as of Q1 2026, up from 671.6K shares the prior filed quarter.

Position Value
$146M
Q1 2026
Shares
673.0K
% of Portfolio
+0.09%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $103MQ4 ’18Q1 ’19: $491MQ2 ’19: $465MQ3 ’19: $399MQ4 ’19: $363MQ4 ’19Q1 ’20: $288MQ2 ’20: $144MQ3 ’20: $56MQ4 ’20: $812,000Q4 ’20Q1 ’21: $2MQ2 ’21: $8MQ3 ’21: $26MQ4 ’21: $37MQ4 ’21Q1 ’22: $45MQ2 ’22: $16MQ3 ’22: $15MQ4 ’22: $20MQ4 ’22Q1 ’23: $21MQ2 ’23: $224MQ3 ’23: $167MQ4 ’23: $165MQ4 ’23Q1 ’24: $135MQ2 ’24: $158MQ3 ’24: $124MQ4 ’24: $40MQ4 ’24Q1 ’25: $130MQ2 ’25: $286MQ3 ’25: $259MQ4 ’25: $153MQ4 ’25Q1 ’26: $146Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026673.0K$146M+0.09%
Q4 2025671.6K$153M+0.08%
Q3 20251.12M$259M+0.15%
Q2 20251.54M$286M+0.20%
Q1 2025622.2K$130M+0.12%
Q4 2024225.2K$40M+0.03%
Q3 2024626.9K$124M+0.11%
Q2 2024918.6K$158M+0.15%
Q1 2024739.7K$135M+0.12%
Q4 20231.07M$165M+0.14%
Q3 20231.12M$167M+0.17%
Q2 20231.66M$224M+0.23%
Q1 2023131.4K$21M+0.02%
Q4 2022126.2K$20M+0.02%
Q3 2022114.6K$15M+0.02%
Q2 2022101.8K$16M+0.02%
Q1 2022276.6K$45M+0.04%
Q4 2021274.1K$37M+0.03%
Q3 2021240.2K$26M+0.02%
Q2 202172.5K$8M+0.01%
Q1 202120.2K$2M0.00%
Q4 20207.6K$812,0000.00%
Q3 2020638.5K$56M+0.06%
Q2 20201.47M$144M+0.17%
Q1 20203.79M$288M+0.45%
Q4 20194.10M$363M+0.41%
Q3 20195.27M$399M+0.49%
Q2 20196.39M$465M+0.58%
Q1 20196.09M$491M+0.63%
Q4 20181.12M$103M+0.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See D. E. Shaw & Co., Inc.’s full portfolio or all institutional holders of ABBV.